CD62L (L-Selectin) Antibody 14-0629-82 from Thermo Fisher Scientific

Product Specs
ItemCD62L (L-Selectin) Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number14-0629-82
Quantity100 µg
ApplicationsFlow Cytometry, Functional assay, Immunohistochemistry (Frozen), Neutralization, Western Blot
Concentration0.5 mg/mL
Conjugate/TagUnconjugated
FormatPBS with 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetCD62L (L-Selectin)
IsotypeIgG1 kappa
CloneDREG-56 (DREG56)
HostMouse
NCBI Full Gene Nameselectin L
NCBI Gene AliasesCD62L, LAM1, LECAM1, LEU8, LNHR, LSEL, LYAM1, PLNHR, TQ1
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C
Antibody TypePrimary
Storage4° C

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(1) Induction of memory-like CD8+ T cells and CD4+ T cells from human naive T cells in cultureClinical and experimental immunologyJanuary 28, 2022Tokumoto Y, Araki Y, Narizuka Y, Mizuno Y, Ohshima S, Mimura T.

(2) Associations between Hypertriglyceridemia and Circulating Neutrophil Subpopulation in Patients with DyslipidemiaInternational journal of inflammationJanuary 1, 2021Genkel V, Dolgushin I, Baturina I, Savochkina A, Kuznetsova A, Pykhova L, Shaposhnik I.

(3) EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung CarcinomasCancersDecember 5, 2020Lachat C, Bruyère D, Etcheverry A, Aubry M, Mosser J, Warda W, Herfs M, Hendrick E, Ferrand C, Borg C, et al.

(5) Internalization of HMGB1 (High Mobility Group Box 1) Promotes Angiogenesis in Endothelial CellsArteriosclerosis, thrombosis, and vascular biologyDecember 1, 2020Lan J, Luo H, Wu R, Wang J, Zhou B, Zhang Y, Jiang Y, Xu J.

(6) C reactive protein impairs adaptive immunity in immune cells of patients with melanomaJournal for immunotherapy of cancerApril 1, 2020Yoshida T, Ichikawa J, Giuroiu I, Laino AS, Hao Y, Krogsgaard M, Vassallo M, Woods DM, Stephen Hodi F, Weber J.

(7) Development of CAR-T cell therapy for B-ALL using a point-of-care approachOncoimmunologyJanuary 1, 2020de Macedo Abdo L, Barros LRC, Saldanha Viegas M, Vieira Codeço Marques L, de Sousa Ferreira P, Chicaybam L, Bonamino MH.

(8) Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptomeNature communicationsSeptember 2, 2019Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, et al.

(11) Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humansThe Journal of clinical investigationJanuary 3, 2017Rathod KS, Kapil V, Velmurugan S, Khambata RS, Siddique U, Khan S, Van Eijl S, Gee LC, Bansal J, Pitrola K, et al.

(14) Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humansJournal of immunology (Baltimore, Md. : 1950)March 1, 2013Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK.

Flow